BR0105486A - New pharmaceutical compound, its processes for obtaining and pharmaceutical compositions containing the same - Google Patents

New pharmaceutical compound, its processes for obtaining and pharmaceutical compositions containing the same

Info

Publication number
BR0105486A
BR0105486A BR0105486-4A BR0105486A BR0105486A BR 0105486 A BR0105486 A BR 0105486A BR 0105486 A BR0105486 A BR 0105486A BR 0105486 A BR0105486 A BR 0105486A
Authority
BR
Brazil
Prior art keywords
processes
compositions containing
pharmaceutical compositions
obtaining
same
Prior art date
Application number
BR0105486-4A
Other languages
Portuguese (pt)
Inventor
Alcebiades De Mendonca Athayde
Original Assignee
Libbs Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Libbs Farmaceutica Ltda filed Critical Libbs Farmaceutica Ltda
Priority to BR0105486-4A priority Critical patent/BR0105486A/en
Publication of BR0105486A publication Critical patent/BR0105486A/en

Links

Abstract

"NOVO COMPOSTO FARMACêUTICO, SEUS PROCESSOS DE OBTENçãO E COMPOSIçõES FARMACêUTICAS CONTENDO O MESMO". A presente invenção é referente ao sulfato de 1-(4-clorofenil)-N,N-dimetil-<244.-(2-metilpropil)-ciclobutanometanami na e seus isómeros, a seus processos de fabricação e composições farmacêuticas, sendo esta uma substância com características higroscópicas reduzidas destinada a fabricação de produtos farmacêuticos."NEW PHARMACEUTICAL COMPOUND, ITS PROCESSING PROCESSES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM". The present invention relates to 1- (4-chlorophenyl) -N, N-dimethyl-? 244.- (2-methylpropyl) -cyclobutanomethanamine sulfate and its isomers, their manufacturing processes and pharmaceutical compositions, which is a substance with reduced hygroscopic characteristics intended for the manufacture of pharmaceutical products.

BR0105486-4A 2001-09-27 2001-09-27 New pharmaceutical compound, its processes for obtaining and pharmaceutical compositions containing the same BR0105486A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR0105486-4A BR0105486A (en) 2001-09-27 2001-09-27 New pharmaceutical compound, its processes for obtaining and pharmaceutical compositions containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0105486-4A BR0105486A (en) 2001-09-27 2001-09-27 New pharmaceutical compound, its processes for obtaining and pharmaceutical compositions containing the same

Publications (1)

Publication Number Publication Date
BR0105486A true BR0105486A (en) 2003-10-07

Family

ID=28047834

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0105486-4A BR0105486A (en) 2001-09-27 2001-09-27 New pharmaceutical compound, its processes for obtaining and pharmaceutical compositions containing the same

Country Status (1)

Country Link
BR (1) BR0105486A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006073292A1 (en) 2005-01-06 2006-07-13 Cj Corporation Inorganic acid salts of sibutramine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006073292A1 (en) 2005-01-06 2006-07-13 Cj Corporation Inorganic acid salts of sibutramine

Similar Documents

Publication Publication Date Title
BR0213063A (en) Double acting antibiotics
BR0215182A (en) (Alpha) - (n-sulfonamido) acetamide derivatives as (beta) -amyloid inhibitors
BR0111233A (en) Micronized Barium Sulphate
ATE406893T1 (en) PHARMACEUTICAL COMPOSITION (KIT) CONTAINING DIHYDROPYRIDINONE COMPOUNDS AND A COMPOUND HAVING IMMUNOMODULATORY (OR ANTI-INFLAMMATORY) ACTION AND USE THEREOF
BRPI0502228A (en) alpha crystalline form of strontium ranelate, process for its preparation, and pharmaceutical compositions containing it
BR0315720A (en) Compound, method for the prophylaxis or treatment of a clinical condition in a mammal, pharmaceutical formulation, combination, use of a compound, process for the preparation of a compound, and, intermediate
BRPI0412824A (en) stable radiopharmaceutical compositions and methods for their preparation
HRP20040358B1 (en) Herbicides containing substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one
BR0306025A (en) Odor Control Coating and Related Manufacturing Articles
ATE409485T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FAB I INHIBITORS AND OTHER ANTIBIOTICS
BR0015449A (en) Coating
AR052853A1 (en) ORAL COMPOSITIONS CONTAINING ANTIBACTERIAL BIFENOL COMPOUNDS
EP2229957A3 (en) Stabilization of aqueous compositions of 18f-isotope labelled 2-fluoro-2-deoxy-d-glucose with ethanol
WO2003016248A3 (en) Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
BRPI0406824A (en) Antibacterial indolonaoxazoldinones, intermediates for their preparation and pharmaceutical compositions containing them
NO20045063L (en) Compositions containing at least one diformate
BR0105486A (en) New pharmaceutical compound, its processes for obtaining and pharmaceutical compositions containing the same
BRPI0408848A (en) oral cladribine formulations
HUP0303860A2 (en) A pharmaceutical tablet having a high active ingredient
BRPI0411973A (en) polymorphic form a of 4- [6-acetyl-3- [3- (4-acetyl-3-hydroxy-2-propylphenylthio) propoxy] -2-propylphenoxy] butyric acid
BRPI0603401A (en) active substance release system and its use
BR9800763A (en) New 2-amino indane compounds, a process for their preparation and pharmaceutical compositions containing them.
BR0316673A (en) Concentrated liquid composition of valdecoxib
ATE459592T1 (en) NAPHTHALINONE DERIVATIVE WITH ODORS OF THE POWDERY IONONE TYPE
HRP20060040A2 (en) PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS, AS WELL AS PROCESS FOR THE SYNTHESIS OF THE MIXTURE OF ISOMERS AND THE PURE ISOMERS

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTEAO DESPACHO 8.6 DA RPI 2014 DE 11/08/2009.